Clinical trial
ImmuneSense Lyme Study
NCT04422314 is registered in ClinicalTrials.gov with Adaptive Biotechnologies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ImmuneSense Lyme Study
- Lead sponsor
- Adaptive Biotechnologies
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 9, 2020
- Completion date
- October 30, 2021
- Enrollment
- 893 (actual)
- Sites
- 34
Conditions
As the registry lists them; a condition with its own page is linked.